Simultaneous Emergence of Multidrug-Resistant Candida auris on 3 Continents Confirmed by Whole-Genome Sequencing and Epidemiological Analyses
Open accessThe DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Candida auris, a multidrug-resistant yeast that causes invasive infections, was first described in 2009 in Japan and has since been reported from several countries. METHODS: To understand the global emergence and epidemiology of C. auris, we obtained isolates from 54 patients with C. auris infection from Pakistan, India, South Africa, and Venezuela during 2012-2015 and the type specimen from Japan. Patient information was available for 41 of the isolates. We conducted antifungal susceptibility testing and whole-genome sequencing (WGS). RESULTS: Available clinical information revealed that 41% of patients had diabetes mellitus, 51% had undergone recent surgery, 73% had a central venous catheter, and 41% were receiving systemic antifungal therapy when C. auris was isolated. The median time from admission to infection was 19 days (interquartile range, 9-36 days), 61% of patients had bloodstream infection, and 59% died. Using stringent break points, 93% of isolates were resistant to fluconazole, 35% to amphotericin B, and 7% to echinocandins; 41% were resistant to 2 antifungal classes and 4% were resistant to 3 classes. WGS demonstrated that isolates were grouped into unique clades by geographic region. Clades were separated by thousands of single-nucleotide polymorphisms, but within each clade isolates were clonal. Different mutations in ERG11 were associated with azole resistance in each geographic clade. CONCLUSIONS: C. auris is an emerging healthcare-associated pathogen associated with high mortality. Treatment options are limited, due to antifungal resistance. WGS analysis suggests nearly simultaneous, and recent, independent emergence of different clonal populations on 3 continents. Risk factors and transmission mechanisms need to be elucidated to guide control measures.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“C. auris, a novel Candida species first identified in 2009, has emerged since 2013 as a cause of nosocomial outbreaks in multiple countries across 5 continents.”
From Treatment of Invasive Candidiasis: A Narrative Review (2018) · cites this paper as [16]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Resistance to all three classes of antifungals is reported most commonly in India in South Asia (3%), whereas this is much less common in other regions of the world.122–124”
From Epidemiology of Invasive Candidiasis (2024) · cites this paper as [122]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Invasive C. auris infections are associated with high mortality rates, with 60% of hospitalizations due to C. auris infections resulting in death (8).”
From Clinical Efficacy and Safety of a Novel Antifungal, Fosmanogepix, in Patients with Candidemia Caused by Candida auris : Results from a Phase 2 Trial (2023) · cites this paper as [8]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Three such mutations, encoding the amino acid substitutions VF125AL (commonly referred to as F126L), Y132F, and K143R, are frequently reported among fluconazole-resistant clinical isolates, and associations between these mutations and specific genetic clades of C. auris have been observed (2).”
From Mutations in TAC1B : a Novel Genetic Determinant of Clinical Fluconazole Resistance in Candida auris (2020) · cites this paper as [2]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Indeed, up to 96% of C. auris may exhibit resistance to fluconazole, an exceptionally high value compared to 0.5–2% for C. albicans, 4–9% for C. tropicalis, 2–6% for C. parapsilosis, and 11–13% for C. glabrata [16,40,41].”
From Evolutionary Emergence of Drug Resistance in Candida Opportunistic Pathogens (2018) · cites this paper as [16]
Experimental — accuracy not yet measured
29 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
MEGA6: Molecular Evolutionary Genetics Analysis Version 6.0
Tamura, K., Stecher, G., Peterson, D., Filipski, A., & Kumar, S. (2013) · Molecular Biology and Evolution · doi:10.1093/molbev/mst197 · Cited by 47,205
The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data
McKenna, A., Hanna, M., Banks, E., Sivachenko, A., Cibulskis, K., Kernytsky, A., Garimella, K., Altshuler, D., Gabriel, S., Daly, M., et al. (2010) · Genome Research · doi:10.1101/gr.107524.110 · Cited by 27,895 · cited 1×
“SNPs were identified using 2 independent pipelines, as described elsewhere (see also the legend to Supplemental Figure 1) [15, 19].”
MethodEpidemiology of Invasive Candidiasis: a Persistent Public Health Problem
Pfaller, M. A., & Diekema, D. J. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00029-06 · Cited by 4,174 · cited 2×
“auris because we did not have a comparison group of patients with other Candida infections from the same institutions [31].”
BackgroundResultNonhybrid, finished microbial genome assemblies from long-read SMRT sequencing data
Chin, C.-S., Alexander, D. H., Marks, P., Klammer, A. A., Drake, J., Heiner, C., Clum, A., Copeland, A., Huddleston, J., Eichler, E. E., et al. (2013) · Nature Methods · doi:10.1038/nmeth.2474 · Cited by 4,029 · cited 1×
“The reference genome was generated by de novo assembly of PacBio reads from isolate B8441, as described elsewhere [18], and used as a reference for single-nucleotide polymorphism (SNP) calling.”
MethodSatoh, K., Makimura, K., Hasumi, Y., Nishiyama, Y., Uchida, K., & Yamaguchi, H. (2009) · Microbiology and Immunology · doi:10.1111/j.1348-0421.2008.00083.x · Cited by 1,381 · cited 8×
“To understand the global emergence and epidemiology of C. auris, we obtained isolates from 54 patients with C. auris infection from Pakistan, India, South Africa, and Venezuela during 2012–2015 and the type specimen from Japan.”
BackgroundInfluentialEvolution of pathogenicity and sexual reproduction in eight Candida genomes
Butler, G., Rasmussen, M. D., Lin, M. F., Santos, M. A. S., Sakthikumar, S., Munro, C. A., Rheinbay, E., Grabherr, M., Forche, A., Reedy, J. L., et al. (2009) · Nature · doi:10.1038/nature08064 · Cited by 1,065 · cited 1×
“5 Mb, similar to that of other Candida species [25].”
BackgroundSelf-citationKathuria, S., Singh, P. K., Sharma, C., Prakash, A., Masih, A., Kumar, A., Meis, J. F., & Chowdhary, A. (2015) · Journal of Clinical Microbiology · doi:10.1128/jcm.00367-15 · Cited by 532 · cited 1×
“It phenotypically resembles Candida haemulonii and requires use of molecular methods for identification [9, 10].”
MethodSelf-citationFirst Three Reported Cases of Nosocomial Fungemia Caused by Candida auris
Lee, W. G., Shin, J. H., Uh, Y., Kang, M. G., Kim, S. H., Park, K. H., & Jang, H.-C. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.00319-11 · Cited by 523 · cited 2×
“auris [3], establishing that this new species was capable of causing invasive infections.”
BackgroundPerea, S., López-Ribot, J. L., Kirkpatrick, W. R., McAtee, R. K., Santillán, R. A., Martı́nez, M., Calabrese, D., Sanglard, D., & Patterson, T. F. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.10.2676-2684.2001 · Cited by 470
Incidence, characteristics and outcome of ICU-acquired candidemia in India
Chakrabarti, A., Sood, P., Rudramurthy, S. M., Chen, S., Kaur, H., Capoor, M., Chhina, D., Rao, R., Eshwara, V. K., Xess, I., et al. (2015) · Intensive Care Medicine · doi:10.1007/s00134-014-3603-2 · Cited by 454 · cited 1×
“auris may become widely established within certain regions, as evidenced by the fact that it now accounts for nearly 5% of candidemia in Indian intensive care units [5].”
Background
Cited by
Items 301–400 of 1,007
Vaseghi, N., Sharifisooraki, J., Khodadadi, H., Nami, S., Safari, F., Ahangarkani, F., Meis, J. F., Badali, H., & Morovati, H. (2022) · Mycoses · doi:10.1111/myc.13471 · Cited by 63
Self-citationGómez-Gaviria, M., Martínez-Álvarez, J. A., Chávez-Santiago, J. O., & Mora-Montes, H. M. (2023) · Infection and Drug Resistance · doi:10.2147/idr.s402754 · Cited by 69
Serious fungal infections in Pakistan
Jabeen, K., Farooqi, J. Q., Mirza, S., Denning, D. W., & Zafar, A. (2017) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-017-2919-6 · Cited by 74
Self-citationErgosterol Biosynthesis and Regulation Impact the Antifungal Resistance and Virulence of Candida spp
Eliaš, D., Tóth Hervay, N., & Gbelská, Y. (2024) · Stresses · doi:10.3390/stresses4040041 · Cited by 63
A common vesicle proteome drives fungal biofilm development
Zarnowski, R., Sanchez, H., Jaromin, A., Zarnowska, U. J., Nett, J. E., Mitchell, A. P., & Andes, D. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2211424119 · Cited by 63
Khan, Z., Ahmad, S., Benwan, K., Purohit, P., Al-Obaid, I., Bafna, R., Emara, M., Mokaddas, E., Abdullah, A. A., Al-Obaid, K., et al. (2018) · Infection · doi:10.1007/s15010-018-1164-y · Cited by 63
Candida auris: A Continuing Threat
Bhargava, A., Klamer, K., Sharma, M., Ortiz, D. A., & Saravolatz, L. I. I. (2025) · Microorganisms · doi:10.3390/microorganisms13030652 · Cited by 72
What’s new on emerging resistant Candida species
Cortegiani, A., Misseri, G., & Chowdhary, A. (2018) · Intensive Care Medicine · doi:10.1007/s00134-018-5363-x · Cited by 67
Self-citationEvolution of drug resistance in an antifungal-naive chronic Candida lusitaniae infection
Demers, E. G., Biermann, A. R., Masonjones, S., Crocker, A. W., Ashare, A., Stajich, J. E., & Hogan, D. A. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1807698115 · Cited by 67
The many faces of Candida auris: Phenotypic and strain variation in an emerging pathogen
Santana, D. J., Zhao, G., & O’Meara, T. R. (2024) · PLOS Pathogens · doi:10.1371/journal.ppat.1012011 · Cited by 62
A systematic review of the impact of antifungal stewardship interventions in the United States
Hart, E. J., Nguyen, M., Allen, M., Clark, C. M., & Jacobs, D. M. (2019) · Annals of Clinical Microbiology and Antimicrobials · doi:10.1186/s12941-019-0323-z · Cited by 63
Lockhart, S. R., Jackson, B. R., Vallabhaneni, S., Ostrosky-Zeichner, L., Pappas, P. G., & Chiller, T. (2017) · Journal of Clinical Microbiology · doi:10.1128/jcm.01355-17 · Cited by 61
“auris isolates from around the world tested at CDC to date were resistant to all three classes of antifungals, making infections with them especially challenging to treat (15).”
BackgroundSelf-citationHernando-Ortiz, A., Mateo, E., Perez-Rodriguez, A., de Groot, P. W. J., Quindós, G., & Eraso, E. (2021) · Virulence · doi:10.1080/21505594.2021.1908765 · Cited by 59
“However, recently Candida auris is emerging as a major cause of invasive nosocomial infections with multidrug-resistance and high morbidity and mortality [3,4].”
BackgroundTools for Detecting a “Superbug”: Updates on Candida auris Testing
Lockhart, S. R., Lyman, M., & Sexton, D. J. (2022) · Journal of Clinical Microbiology · doi:10.1128/jcm.00808-21 · Cited by 65
“auris is the fact that there are five different clades (including a few cases from clade V so far identified only in Iran) and the clades have both different assimilation profiles and slight differences in their rDNA sequences (2, 14).”
BackgroundSelf-citationde Melo, C. C., de Sousa, B. R., da Costa, G. L., Oliveira, M. M. E., & de Lima-Neto, R. G. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1033707 · Cited by 66
“Since then, it has been reported on all continents, with the exception of Antarctica, both as a causative agent of invasive infections and as a colonizer (Lockhart et al., 2017; Lone and Ahmad, 2019; Chow et al., 2020; Sabino et al., 2020).”
BackgroundOng, C. W., Chen, S. C. ‐., Clark, J. E., Halliday, C. L., Kidd, S. E., Marriott, D. J., Marshall, C. L., Morris, A. J., Morrissey, C. O., Roy, R., et al. (2019) · Internal Medicine Journal · doi:10.1111/imj.14612 · Cited by 58
Clade II Candida auris possess genomic structural variations related to an ancestral strain
Sekizuka, T., Iguchi, S., Umeyama, T., Inamine, Y., Makimura, K., Kuroda, M., Miyazaki, Y., & Kikuchi, K. (2019) · PLOS ONE · doi:10.1371/journal.pone.0223433 · Cited by 59
“using these SNVs indicated the existence of 4 distinct clades (Fig 1), which closely relate to the geographic location, and are consistent with a previous report [13,23,24].”
BackgroundResultInfluentialSharma, D., Paul, R. A., Rudramurthy, S. M., Kashyap, N., Bhattacharya, S., Soman, R., Shankarnarayan, S. A., Chavan, D., Singh, S., Das, P., et al. (2022) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01652-21 · Cited by 60
“5% resistance rate reported in earlier studies (9, 10, 17, 23).”
BackgroundCastanheira, M., Deshpande, L. M., Davis, A. P., Carvalhaes, C. G., & Pfaller, M. A. (2022) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2022.05.004 · Cited by 63
Self-citationRapid and extensive karyotype diversification in haploid clinical Candida auris isolates
Bravo Ruiz, G., Ross, Z. K., Holmes, E., Schelenz, S., Gow, N. A. R., & Lorenz, A. (2019) · Current Genetics · doi:10.1007/s00294-019-00976-w · Cited by 60
Multidrug transporters of Candida species in clinical azole resistance
Prasad, R., Nair, R., & Banerjee, A. (2019) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2019.103252 · Cited by 57
Deciphering the Mrr1/Mdr1 Pathway in Azole Resistance of Candida auris
Li, J., Coste, A. T., Bachmann, D., Sanglard, D., & Lamoth, F. (2022) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00067-22 · Cited by 59
Shivarathri, R., Jenull, S., Stoiber, A., Chauhan, M., Mazumdar, R., Singh, A., Nogueira, F., Kuchler, K., Chowdhary, A., & Chauhan, N. (2020) · mSphere · doi:10.1128/msphere.00973-20 · Cited by 59
“auris isolates into four phylogenetically distinct clades (6), with a potential fifth clade emerging from Iran (7).”
BackgroundSelf-citationMartins‐Santana, L., Rezende, C. P., Rossi, A., Martinez-Rossi, N. M., & Almeida, F. B. D. R. (2023) · Pathogens · doi:10.3390/pathogens12020293 · Cited by 66
“Mortality rates caused by this pathogen are high, up to 70%, particularly in cases of candidemia [37,38].”
BackgroundSharma, C., & Kadosh, D. (2023) · PLoS Pathogens · doi:10.1371/journal.ppat.1011190 · Cited by 63
“Several new antifungal agents with potential therapeutic effects against C. auris have been developed that are undergoing Phase II or Phase III clinical trials.”
BackgroundInfluentialGamaletsou, M. N., Walsh, T. J., & Sipsas, N. V. (2018) · Turkish Journal of Hematology · doi:10.4274/tjh.2018.0007 · Cited by 64
“The recent outbreaks of multidrug-resistant Candida auris [13] in many hematology centers around the world and the increasing reports of infections caused by panresistant Lomentospora prolificans [14,15] are characteristic examples.”
BackgroundBougnoux, M., Brun, S., & Zahar, J. (2018) · Antimicrobial Resistance and Infection Control · doi:10.1186/s13756-018-0338-9 · Cited by 64
“auris deep infections observed during 2012–2015; 73%, occurred in patients having a central venous catheter (CVC), 61% with a urinary catheter, 51% had undergone recent surgery, and 41% had diabetes mellitus [14].”
BackgroundTian, S., Rong, C., Nian, H., Li, F., Chu, Y., Cheng, S., & Shang, H. (2018) · Emerging Microbes & Infections · doi:10.1038/s41426-018-0131-0 · Cited by 58
First report of Candida auris infections from Saudi Arabia
Abdalhamid, B. A., Almaghrabi, R. S., Althawadi, S., & Omrani, A. S. (2018) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2018.05.010 · Cited by 61
Wall, G., Herrera, N., & Lopez-Ribot, J. L. (2019) · Journal of Fungi · doi:10.3390/jof5040092 · Cited by 58
Ongoing Challenges with Healthcare-Associated Candida auris Outbreaks in Oman
Al Maani, A., Paul, H., Al-Rashdi, A., Al Wahaibi, A., Al-Jardani, A., Al Abri, A. M. A., AlBalushi, M. A. H., Al Abri, S., Al Reesi, M., Al Maqbali, A., et al. (2019) · Journal of Fungi · doi:10.3390/jof5040101 · Cited by 57
Self-citationActivity of novel antifungal compound APX001A against a large collection of Candida auris
Berkow, E. L., & Lockhart, S. R. (2018) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dky302 · Cited by 57
Self-citationThe future of fungi: threats and opportunities
Case, N. T., Berman, J. G., Blehert, D. S., Cramer, R. A., Cuomo, C. A., Currie, C. R., Ene, I. V., Fisher, M. C., Fritz‐Laylin, L. K., Gerstein, A. C., et al. (2022) · G3 Genes Genomes Genetics · doi:10.1093/g3journal/jkac224 · Cited by 62
Self-citationComprehensive Overview of Candida auris : An Emerging Multidrug-Resistant Fungal Pathogen
Kim, J.-S., Cha, H., & Bahn, Y. (2024) · Journal of Microbiology and Biotechnology · doi:10.4014/jmb.2404.04040 · Cited by 63
Burden of Fungal Infections in Colombia
Álvarez, C., Cortés, J. A., & Denning, D. W. (2018) · Journal of Fungi · doi:10.3390/jof4020041 · Cited by 57
Consensus guidelines for antifungal stewardship, surveillance and infection prevention, 2021
Khanina, A., Tio, S. Y., Ananda-Rajah, M. R., Kidd, S. E., Williams, E., Chee, L. C. Y., Urbancic, K. F., & Thursky, K. (2021) · Internal Medicine Journal · doi:10.1111/imj.15586 · Cited by 63
International Multicentre Study of Candida auris Infections
Pandya, N., Cag, Y., Pandak, N., Pekok, A. U., Poojary, A., Ayoade, F., Fasciana, T., Giammanco, A., Caskurlu, H., Rajani, D. P., et al. (2021) · Journal of Fungi · doi:10.3390/jof7100878 · Cited by 56
Novel Environmental Niches for Candida auris: Isolation from a Coastal Habitat in Colombia
Escandón, P. (2022) · Journal of Fungi · doi:10.3390/jof8070748 · Cited by 57
“auris date from 2009 in Japan [3], but the number of infections and colonizations detonated two years later, with the appearance of this pathogen in different hospital settings, which has emerged independently and simultaneously in most parts of the world with different evolutionary histories and genome-wide patterns…”
BackgroundParker, R. A., Gabriel, K. T., Graham, K., Butts, B. K., & Cornelison, C. T. (2022) · Pathogens · doi:10.3390/pathogens11080821 · Cited by 61
“These clades are purported to have emerged simultaneously, and their identity has been confirmed by whole-genome sequencing, which has identified thousands of single-nucleotide polymorphisms [17].”
BackgroundGaining Insights from Candida Biofilm Heterogeneity: One Size Does Not Fit All
Kean, R., Delaney, C., Rajendran, R., Sherry, L., Metcalfe, R., Thomas, R., McLean, W., Williams, C., & Ramage, G. (2018) · Journal of Fungi · doi:10.3390/jof4010012 · Cited by 55
“There has been a simultaneous emergence of distinct clades of this organism in different geographical locations, currently categorised into the East Asian, South Asian, South American, and South African clades [99,100].”
BackgroundThe Emerging Threat of Antifungal Resistance in Transplant Infectious Diseases
Schwartz, I. S., & Patterson, T. F. (2018) · Current Infectious Disease Reports · doi:10.1007/s11908-018-0608-y · Cited by 57
In vitro and in vivo Effect of Exogenous Farnesol Exposure Against Candida auris
Nagy, F., Vitális, E., Jakab, Á., Borman, A. M., Forgács, L., Tóth, Z., Majoros, L., & Kovács, R. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.00957 · Cited by 58
“Alarmingly, isolates of C. auris with resistance to all three major antifungal classes have been reported in multiple countries including the United States (Ostrowsky et al., 2020).”
BackgroundInfluentialKhunweeraphong, N., & Kuchler, K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094806 · Cited by 53
Susceptibility testing of fungi to antifungal drugs
Sanguinetti, M., & Posteraro, B. (2018) · Journal of Fungi · doi:10.3390/jof4030110 · Cited by 55
Asadzadeh, M., Mokaddas, E., Ahmad, S., Abdullah, A. A., de Groot, T., Meis, J. F., & Shetty, S. A. (2022) · Mycoses · doi:10.1111/myc.13419 · Cited by 55
Self-citationCandida Bloodstream Infections: Changes in Epidemiology and Increase in Drug Resistance
Kotey, F. C. N., Dayie, N. T. K. D., Tetteh‐Quarcoo, P. B., & Donkor, E. S. (2021) · Infectious Diseases Research and Treatment · doi:10.1177/11786337211026927 · Cited by 77
Jones, C. R., Neill, C., Borman, A. M., Budd, E. L., Cummins, M. N., Fry, C., Guy, R. L., Jeffery, K. J., Johnson, E. M., Manuel, R. J., et al. (2024) · Journal of Medical Microbiology · doi:10.1099/jmm.0.001820 · Cited by 61
Prevalence and Therapeutic Challenges of Fungal Drug Resistance: Role for Plants in Drug Discovery
Marquez, L., & Quave, C. L. (2020) · Antibiotics · doi:10.3390/antibiotics9040150 · Cited by 63
“auris isolates analyzed displayed resistance to the azole fluconazole [19].”
BackgroundInfluentialAntifungal Activity of a Medical-Grade Honey Formulation against Candida auris
de Groot, T., Janssen, T., Faro, D., Cremers, N. A. J., Chowdhary, A., & Meis, J. F. G. M. (2021) · Journal of Fungi · doi:10.3390/jof7010050 · Cited by 58
“auris can genotypically be divided into five different clades, from South Asia (I), East Asia (II), Africa (III), South America (IV), and Iran (V) [6,7].”
BackgroundSelf-citationThe global challenge of Candida auris in the intensive care unit
Cortegiani, A., Misseri, G., Giarratano, A., Bassetti, M., & Eyre, D. (2019) · Critical Care · doi:10.1186/s13054-019-2449-y · Cited by 54
de Alteriis, E., Maione, A., Falanga, A., Bellavita, R., Galdiero, S., Albarano, L., Salvatore, M. M., Galdiero, E., & Guida, M. (2021) · Antibiotics · doi:10.3390/antibiotics11010026 · Cited by 54
“auris as an emerging “superbug” has b en released [27,28].”
BackgroundBillamboz, M., Fatima, Z., Hameed, S., & Jawhara, S. (2021) · Microorganisms · doi:10.3390/microorganisms9030634 · Cited by 56
“Chow, N.A.; de Groot, T.; Badali, H.; Abastabar, M.; Chiller, T.M.; Meis, J.F. Potential Fifth Clade of Candida auris, Iran, 2018.”
BackgroundInfluentialAzole resistance in Candida auris: mechanisms and combinatorial therapy
Jangir, P., Kalra, S., Tanwar, S., & Bari, V. K. (2023) · Apmis · doi:10.1111/apm.13336 · Cited by 61
Arendrup, M. C., Chowdhary, A., Astvad, K. M. T., & Jørgensen, K. M. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01225-18 · Cited by 53
“auris isolates harbored ERG11 target gene alterations (16, 18).”
BackgroundSelf-citationThe emerging pathogen Candida auris: A focus on the Middle-Eastern countries
Alfouzan, W., Dhar, R., Albarrag, A., & Al-Abdely, H. (2019) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2019.03.009 · Cited by 52
Mohammad, H., Eldesouky, H. E., Hazbun, T., Mayhoub, A. S., & Seleem, M. N. (2019) · Scientific Reports · doi:10.1038/s41598-019-55379-1 · Cited by 55
Colistin interacts synergistically with echinocandins against Candida auris
Bidaud, A.-L., Djènontin, E., Botterel, F., Chowdhary, A., & Dannaoui, É. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.105901 · Cited by 56
Self-citationMayr, E.-M., Ramírez-Zavala, B., Krüger, I., & Morschhäuser, J. (2020) · mSphere · doi:10.1128/msphere.00279-20 · Cited by 55
“auris have been identified and named according to their geographic origin: South Asian (clade I), East Asian (clade II), South African (clade III), and South American (clade IV) (3).”
BackgroundAl-Rashdi, A., Al-Maani, A. S., Wahaibi, A. S. A., Alqayoudhi, A., Al‐Jardani, A., & Al-Abri, S. (2021) · Journal of Fungi · doi:10.3390/jof7010031 · Cited by 58
“found that 4% of the isolates studied were pan-resistant, involving patients from Pakistan, India, South Africa, and Venezuela [34].”
BackgroundVinayagamoorthy, K., Pentapati, K. C., & Prakash, H. (2022) · Mycoses · doi:10.1111/myc.13447 · Cited by 53
Otomastoiditis caused by Candida auris: Case report and literature review
Choi, H. I., An, J., Hwang, J. J., Moon, S., & Son, J. S. (2017) · Mycoses · doi:10.1111/myc.12617 · Cited by 51
Gaitán, A. C. R., Fernández-Pereira, J., Valentín, E., Tormo‐Más, M. Á., Eraso, E., Pemán, J., & de Groot, P. W. J. (2018) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2018.06.014 · Cited by 59
Vatanshenassan, M., Boekhout, T., Mauder, N., Robert, V., Maier, T. H. P., Meis, J. F. G. M., Berman, J. G., Then, E., Kostrzewa, M., & Hagen, F. (2020) · Journal of Fungi · doi:10.3390/jof6030146 · Cited by 54
“Isolates used in this study were collected from different geographical regions, and belonged to the previously defined four major clades based on molecular studies [1,14,17,19,26,39].”
BackgroundMethodSelf-citationBabler, K. M., Sharkey, M. E., Arenas, S. P., Amirali, A., Beaver, C. C., Comerford, S. T., Goodman, K. W., Grills, G. S., Holung, M., Kobetz, E. N., et al. (2023) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2023.165459 · Cited by 54
Lee, K. K., Kubo, K., Abdelaziz, J. A., Cunningham, I., de Silva Dantas, A., Chen, X., Okada, H., Ohya, Y., & Gow, N. A. R. (2018) · The Cell Surface · doi:10.1016/j.tcsw.2018.09.001 · Cited by 52
Hata, D. J., Humphries, R., Lockhart, S. R., & for the College of American Pathologists Microbiology Committee (2020) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2018-0508-ra · Cited by 49
Self-citationCortés, J. A., Ruiz, J. F., Moreno, L. N. M., & Lemos, E. V. (2020) · Biomédica · doi:10.7705/biomedica.4400 · Cited by 61
Wiederhold, N. P., Najvar, L. K., Olivo, M., Morris, K. N., Patterson, H. P., Catano, G., & Patterson, T. F. (2021) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02694-20 · Cited by 53
“In one retrospective review of 54 patients, most of whom had multiple risk factors for invasive disease, candidemia was observed in 61% and the mortality rate was 59% (4).”
BackgroundInfluentialDeciphering the epidemiology of invasive candidiasis in the intensive care unit: is it possible?
Soulountsi, V., Schizodimos, T., & Kotoulas, S. (2021) · Infection · doi:10.1007/s15010-021-01640-7 · Cited by 59
Dickwella Widanage, M. C., Singh, K., Li, J., Yarava, J. R., Scott, F. J., Xu, Y., Gow, N. A. R., Mentink-Vigier, F., Wang, P., Lamoth, F., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-61678-1 · Cited by 51
Álvarez, C., Morales-López, S. E., Rodríguez, G. J., Rodríguez, J. Y., Robert, E., Picot, C., Ceballos-Garzón, A., Parra‐Giraldo, C. M., & Pape, P. L. (2023) · Journal of Fungi · doi:10.3390/jof9040430 · Cited by 59
Boyce, J. M. (2024) · Antimicrobial Resistance and Infection Control · doi:10.1186/s13756-024-01461-x · Cited by 66
Candida auris Infection Leading to Nosocomial Transmission, Israel, 2017
Belkin, A., Gazit, Z., Keller, N., Ben-Ami, R., Wieder-Finesod, A., Novikov, A., Rahav, G., & Brosh-Nissimov, T. (2018) · Emerging Infectious Diseases · doi:10.3201/eid2404.171715 · Cited by 51
“Currently, the Centers for Disease Control and Prevention (CDC) estimates that <10 persons are reported to have rubella annually in the United States (2).”
BackgroundInfluentialArensman, K., Miller, J. L., Chiang, A., Mai, N., Levato, J., LaChance, E., Anderson, M., Beganovic, M., & Dela Pena, J. (2020) · Emerging Infectious Diseases · doi:10.3201/eid2605.191588 · Cited by 52
“In a grouping of 54 isolates from 5 countries, 93% were resistant to fluconazole, 35% to amphotericin B, and 7% to echinocandins (16).”
BackgroundInfluentialMba, I. E., & Nweze, E. I. (2020) · World Journal of Microbiology and Biotechnology · doi:10.1007/s11274-020-02940-0 · Cited by 54
Role of Antifungal Combinations in Difficult to Treat Candida Infections
Vitale, R. G. (2021) · Journal of Fungi · doi:10.3390/jof7090731 · Cited by 52
Zhu, Y., Kilburn, S., Kapoor, M., Chaturvedi, S., Shaw, K. J., & Chaturvedi, V. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01124-20 · Cited by 50
“variable patterns of resistance to amphotericin B, azoles, and echinocandins; (3) MGX”
BackgroundResultThe Novel Arylamidine T-2307 Demonstrates In Vitro and In Vivo Activity against Candida auris
Wiederhold, N. P., Najvar, L. K., Jaramillo, R., Olivo, M., Patterson, H., Connell, A., Fukuda, Y., Mitsuyama, J., Catano, G., & Patterson, T. F. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02198-19 · Cited by 50
“Candida auris is an emerging fungal pathogen that has now been detected in institutions on multiple continents (1, 2).”
BackgroundOutbreaks of Fungal Infections in Hospitals: Epidemiology, Detection, and Management
Douglas, A. P., Stewart, A. G., Halliday, C. L., & Chen, S. C. ‐. (2023) · Journal of Fungi · doi:10.3390/jof9111059 · Cited by 59
“The first global genomic analyses of C. auris isolates indicate near-simultaneous emergence of the pathogen [144], and numerous studies have described its genetic diversity and population structure [143,144,146,147] (summarized in Forsberg et al. [141]).”
BackgroundWurster, S., Bandi, A., Beyda, N. D., Albert, N. D., Raman, N. M., Raad, I. I., & Kontoyiannis, D. P. (2019) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkz100 · Cited by 52
Abrogation of pathogenic attributes in drug resistant Candida auris strains by farnesol
Srivastava, V., & Ahmad, A. (2020) · PLoS ONE · doi:10.1371/journal.pone.0233102 · Cited by 51
Dennis, E. K., Chaturvedi, S., & Chaturvedi, V. P. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.757835 · Cited by 51
Arendrup, M. C., Chowdhary, A., Jørgensen, K. M., & Meletiadis, J. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00656-20 · Cited by 49
“The ethanol-formic acid extraction procedure was followed according to the manufacturer’s protocol for the identification of yeast isolates (7, 18).”
BackgroundMethodSelf-citationInvasive Fungal Diseases in Africa: A Critical Literature Review
Bongomin, F., Ekeng, B. E., Kibone, W., Nsenga, L., Olum, R., Itam-Eyo, A. E., Kuate, M. P. N., Pebolo, P. F., Davies, A. A., Manga, M., et al. (2022) · Journal of Fungi · doi:10.3390/jof8121236 · Cited by 53
da Silva, K. J. G., Lucini, F., Santos, R., Santos, D. A., Meis, J. F. G. M., Melhem, M. D. S. C., Peres, N. T. A., Bastos, R. W., & Rossato, L. L. (2025) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2025.04.003 · Cited by 56
Self-citationArıkan-Akdağlı, S., Ghannoum, M. A., & Meis, J. F. G. M. (2018) · Journal of Fungi · doi:10.3390/jof4040129 · Cited by 54
Self-citationRuiz-Gaitán, A. C., Cantón, E., Fernández-Rivero, M. E., Ramírez, P., & Pemán, J. (2019) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2019.02.005 · Cited by 48
Candida auris in Germany and Previous Exposure to Foreign Healthcare
Hamprecht, A., Barber, A. E., Mellinghoff, S. C., Thelen, P., Walther, G., Yu, Y., Neurgaonkar, P., Dandekar, T., Cornely, O. A., Martin, R., et al. (2019) · Emerging Infectious Diseases · doi:10.3201/eid2509.190262 · Cited by 48
“No SNP pruning (removal of closely spaced SNPs) was performed to better separate closely related isolates.”
ResultInfluentialAgyeman, W. Y., Bisht, A., Gopinath, A., Cheema, A. H., Chaludiya, K., Khalid, M., Nwosu, M., Konka, S., & Khan, S. (2022) · Cureus · doi:10.7759/cureus.29956 · Cited by 71
“glabrata had the highest resistance rate [38].”
BackgroundMethodInfluentialAdhesins in the virulence of opportunistic fungal pathogens of human
Kumari, A., Tripathi, A. H., Gautam, P., Gahtori, R., Pande, A., Singh, Y. P., Madan, T., & Upadhyay, S. K. (2021) · Mycology: An International Journal on Fungal Biology · doi:10.1080/21501203.2021.1934176 · Cited by 56
“This strain is resistant to the first line antifungal agents viz., fluconazole, amphotericin B and echinocandins (Lockhart et al. 2017).”
BackgroundCandida auris: A Mini Review on Epidemiology in Healthcare Facilities in Asia
Thatchanamoorthy, N., Rukumani, D. V., Samudi, C., & Tay, S. T. (2022) · Journal of Fungi · doi:10.3390/jof8111126 · Cited by 54
“The single nucleotide polymorphisms (SNP) differences observed between the isolates from each clade suggest the dynamic evolution of the organism [9].”
BackgroundEmergence of zoonotic sporotrichosis in Brazil: a genomic epidemiology study
dos Santos, A. R., Misas, E., Min, B., Le, N., Bagal, U. R., Parnell, L. A., Sexton, D. J., Lockhart, S. R., Melhem, M. D. S. C., Takahashi, J. P. F., et al. (2024) · The Lancet Microbe · doi:10.1016/s2666-5247(23)00364-6 · Cited by 54
“23 The timings of both S brasiliensis and C auris emergences are also similar and date back to the 1990s.”
Self-citationArendrup, M. C., Guinea, J., Arıkan-Akdağlı, S., Meijer, E. F. J., Meis, J. F. G. M., Buil, J. B., Dannaoui, É., Giske, C. G., Lysková, P., Meletiadis, J., et al. (2025) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2025.07.002 · Cited by 55
Self-citationRare fungal infectious agents: a lurking enemy
Skiada, A., Pavleas, I., & Drogari‐Apiranthitou, M. (2017) · F1000Research · doi:10.12688/f1000research.11124.1 · Cited by 52
“Whole genome sequencing (WGS) and epidemiological analyses, performed by Lockhart et al ., led to the conclusion that this species has emerged recently, independently, and almost simultaneously on three continents and not as a result of worldwide dissemination of a dominant clone 12 .”
BackgroundInfluentialPhenotypic switching in newly emerged multidrug-resistant pathogen Candida auris
Bentz, M. L., Sexton, D. J., Welsh, R. M., & Litvintseva, A. P. (2019) · Medical Mycology · doi:10.1093/mmy/myy100 · Cited by 44
Self-citationMohsin, J., Weerakoon, S., Ahmed, S., Puts, Y., Al Balushi, Z., Meis, J. F., & Al-Hatmi, A. M. S. (2020) · Antibiotics · doi:10.3390/antibiotics9100638 · Cited by 43
Self-citationRomera, D., Aguilera-Correa, J.-J., García-Coca, M., Mahillo-Fernández, I., Viñuela-Sandoval, L., García-Rodríguez, J., & Esteban, J. (2020) · Pathogens and Disease · doi:10.1093/femspd/ftaa067 · Cited by 48
Tian, S., Bing, J., Chu, Y., Chen, J., Cheng, S., Wang, Q., Zhang, J., Ma, X., Zhou, B., Liu, L., et al. (2021) · Emerging Microbes & Infections · doi:10.1080/22221751.2021.1934557 · Cited by 47
“Identification of mutations in the ERG11 and FKS1 genes The VF125AL and I74L mutations located in the Erg11 amino acid sequence for all 93 C. auris highly resistant to fluconazole, as well as the S639F mutation located in the Fks1 amino acid sequence for two stains (RICU7_A33 and RICU7_A34) resistant to echinocandin,…”
BackgroundInfluentialDhasarathan, P., AlSalhi, M. S., Devanesan, S., Subbiah, J., Ranjitsingh, A. J. A., Binsalah, M. A., & Alfuraydi, A. A. (2021) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2021.11.002 · Cited by 48
Unique Cell Surface Mannan of Yeast Pathogen Candida auris with Selective Binding to IgG
Yan, L., Xia, K., Yu, Y., Miliakos, A., Chaturvedi, S., Zhang, F., Chen, S., Chaturvedi, V., & Linhardt, R. J. (2020) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.9b00450 · Cited by 47
Metadata
- Authors
- Lockhart, S. R., Etienne, K. A., Vallabhaneni, S., Farooqi, J., Chowdhary, A., Govender, N. P., Colombo, A. L., Calvo, B., Cuomo, C. A., Desjardins, C. A., Berkow, E. L., Castanheira, M., Magobo, R. E., Jabeen, K., Asghar, R. J., Meis, J. F., Jackson, B., Chiller, T., & Litvintseva, A. P.
- Affiliations
- Centers for Disease Control and Prevention (US)
- Aga Khan University (PK)
- University of Delhi (IN)
- National Health Laboratory Service (ZA)
- Universidade Federal de São Paulo (BR)
- Universidad del Zulia (VE)
- Broad Institute (US)
- JMI Laboratories (US)
- Radboud University Nijmegen (NL)
- ORCID
- Lockhart, Shawn R.
- Vallabhaneni, Snigdha
- Farooqi, Joveria
- Chowdhary, Anuradha
- Govender, Nelesh P.
- Colombo, Arnaldo Lopes
- Cuomo, Christina A.
- Desjardins, Christopher A.
- Berkow, Elizabeth L.
- Castanheira, Mariana
- Magobo, Rindidzani E.
- Jabeen, Kauser
- Asghar, Rana J.
- Meis, Jacques F.
- Jackson, Brendan
- Chiller, Tom
- Litvintseva, Anastasia P.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2016-10-20
- Volume
- 64
- Issue
- 2
- Pages
- 134-140
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- PMC
- PMC5215215
- OpenAlex
- W2536287248
- Semantic Scholar
- c8d8e54651d8fb7a7ece68270cd2630d1cd0df39
- Cited by
- 1,662
- References
- 32
- Citations by year
- 2026: 196 · 2025: 194 · 2024: 203 · 2023: 186 · 2022: 160 · 2021: 178 · 2020: 187 · 2019: 152 · 2018: 116 · 2017: 81 · 2016: 5
- FWCI
- 108.27
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- public-domain
- Locations
- Clinical Infectious Diseases (publishedVersion, public-domain)
- Europe PMC (PubMed Central) (publishedVersion, public-domain)
- PubMed Central (publishedVersion, public-domain)
- PubMed (publishedVersion)
- HighWire Press Open Archive (submittedVersion)
- UNIFESP Institutional Repository (Universidade Federal de São Paulo) (submittedVersion)
- Radboud Repository (Radboud University) (submittedVersion)
- Funders
- National Institute of Allergy and Infectious Diseases (U19AI110818)
- United States Agency for International Development (4-338/PAK-US/HEC/2010/932)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Life Sciences › Immunology and Microbiology › Microbiology › Yeasts and Rust Fungi Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
- Keywords
- Candida auris, multidrug resistance, antifungal resistance, clonal populations, ERG11 mutations, azole resistance, fluconazole resistance, bloodstream infection, invasive candidiasis, nosocomial infections, risk factors, transmission, whole genome sequencing, antifungal susceptibility
- MeSH terms
- Whole Genome Sequencing, Adolescent, Adult, Aged, Antifungal Agents, Candida, Candidiasis, Child, Child, Preschool, Cytochrome P-450 Enzyme System, Female, Humans, Infant, Infant, Newborn, Male, Microbial Sensitivity Tests, Middle Aged, Mutation, Phylogeny, RNA, Ribosomal, 28S, Global Health, Genome, Fungal, Drug Resistance, Multiple, Polymorphism, Single Nucleotide, DNA, Ribosomal Spacer, Drug Resistance, Fungal, Young Adult, Candidemia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.